Oral immunotherapy with low allergenic hydrolysed egg in egg allergic children
Allergy2016Vol. 71(11), pp. 1575–1584
Citations Over TimeTop 10% of 2016 papers
Stavroula Giavi, Yvonne M. Vissers, Antonella Muraro, Roger Lauener, Anastasios P Konstantinopoulos, Annick Mercenier, Antoine Wermeille, Francesca Lazzarotto, Remo Frei, Roberta Bonaguro, Selina Summermatter, Sophie Nutten, Nikolaos G. Papadopoulos
Abstract
HydE can be regarded as a safe, low allergenic product to use in children allergic to egg. Although not significant, HydE given for 6 months increased numerically the proportion of patients becoming tolerant to egg. HydE induced a modulation of the immune response towards better tolerance. A longer treatment period and/or a higher dose may improve the clinical outcome and should be evaluated.
Related Papers
- → Tolerance to heated egg in egg allergy: Explanations and implications for prevention and treatment(2023)11 cited
- → Baked egg oral immunotherapy desensitizes baked egg allergic children to lightly cooked egg(2018)24 cited
- → Evaluation of baked egg oral immunotherapy in French children with hen's egg allergy(2020)20 cited
- → Review for "Evaluation of baked egg oral immunotherapy in French children with hen’s egg allergy"(2020)
- → Review for "Evaluation of baked egg oral immunotherapy in French children with hen’s egg allergy"(2020)